🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Antoine Roquilly

ORCID: 0000-0002-1029-6242

Also affiliated with Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique de Nantes, Imation (United States), Nantes Université

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial”.

Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Rheumatology(2022)10.1016/s2665-9913(22)00044-3

N/A

1.8DataRank · unranked

47 citations

Martti Antila, Joachim H. Ficker, И. Г. Гордеев, Alfredo G. Guerreros, Amparo López‐Bernús +15 more

A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells

The Journal of Cell Biology(2022)10.1083/jcb.202110125

N/A

0DataRank · unranked

24 citations

Jacinta M. Wubben, Cristian Pinero Garcia, Sebastián Cruz-Gómez, Jieru Deng, Jeffrey Y. W. Mak +13 more

Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation

Science(2025)10.1126/science.adr6322

N/A

0DataRank · unranked

7 citations

Yuting Yan, Xiaoyue Zhang, Calum J. Walsh, Emmanuel Montassier, Sinha Debajyoti +27 more